|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
British Columbia Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing British ColumbiaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Xenon Pharmaceuticals Inc.
| | | Phone: | (604) 484-3300 | Fax: | (604) 484-3450 | Year Established: | 1996 | Employees: | 70 | Ticker: | XENE | Exchange: | NASDAQ | Main Contact: | Robin Sherrington, Ph.D., VP Business & Corporate Development | | Other Contacts: | Y. Paul Goldberg, MBChB, Ph.D., FRCPC, Senior VP, Clinical Development Ernesto Aycardi, MD, CMO James R. Empfield, Ph.D., Senior VP, Drug Discovery Charles Cohen, Ph.D., VP, Biology Ian C. Mortimer, CFO & COO Simon Pimstone, MD, PhD, FRCPC, President & CEO
| | Company Description | Xenon is a privately owned, clinical genetics-based drug discovery and development company engaged in developing small molecule therapies based on the genetic causes of select metabolic, neurological and cardiovascular diseases. | |
|
|
|
|
|